-
02 July 2025 07:13:09
- Source: Sharecast

ASX/AIM Announcement 2 July 2025
Wellnex Life Limited (ASX/AIM:WNX)
Company Update
Divestment of The Iron Company
Wellnex Life Limited ("Wellnex" or the "Company") (ASX:WNX AIM:WNX), an innovative consumer healthcare business with a track record for developing, licensing, and marketing products and brands to customers in the growing healthcare market segment, is pleased to provide the following update.
After the successful listing on London's AIM market in March this year, the Board commenced an internal review of its operations to identify key brand assets to focus on, and invest in, over the medium to long term.
As part of this ongoing review, the Company has divested the assets of The Iron Company brand to CW Retail Holdings Pty Ltd (part of the Chemist Warehouse group), effective 30th June 2025 for no cash consideration, in lieu of trade activity that supports our Pain Away, Wakey Wakey and Nighty Night brands within the Chemist Warehouse group.
Joint CEO Zack Bozinovski commented "The Iron Company brand contributed less than 0.5% to Wellnex's gross margins and with our renewed strategy to focus on our key major brands such as Pain Away, Wakey Wakey and Nighty Night, the Company has taken the opportunity to divest the brand.".
This ASX/AIM announcement has been authorised by the Board of Wellnex Life Limited (ASX/AIM:WNX).
For further information, please contact:
Wellnex Life Limited (ASX:WNX) Reach Markets
George Karafotias or Zack Bozinovski T: 1300 805 9419
Joint Chief Executive Officers E: IR@reachmarkets.com.au
P: +61 3 8399 9419
E: george.k@Wellnexlife.com.au
UK Investors
Strand Hanson (Financial & Nominated Advisor)
James Harris / Richard Johnson / Robert Collins Tel: +44 (0) 20 7409 3494
Orana Corporate LLP (Joint Broker) swykeham@oranacorp.com
Sebastian Wykeham
S.P. Angel Corporate Finance LLP (Joint Broker) Tel: +44 (0)20 3470 0470
David Hignell / Vadim Alexandre
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.